ESG risk score 21.46
Environmental score 2.54
Social score 13.53
Governance score 5.39
ESG risk category Medium
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
BeOne Medicines Ltd - ADR
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol ONC:xnas
Currency USD
NASDAQ
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Ready to start investing?
Trade stocks with a regulated broker present in Singapore since 2006.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) -7.87%
1 year 9.98%
3 years 55.42%
Data provided by 
Key stats
Price/earnings (LTM) 62.46
Dividend yield (LTM) -
EPS (LTM) 4.48
Volatility (30 days) 27.41%
Data provided by
Analyst consensus
Average rating Buy
Rating Analysts
Buy
19
Overweight
4
Hold
1
Underweight
0
Sell
0
Target price 414.15
Implied return 47.97%
Last updated 13-Jun-2026
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About BeOne Medicines Ltd - ADR
Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company’s main product is Brukinsa, which is a small-molecule drug that treats multiple forms of Non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up for 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has a global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes with AbbVie and AstraZeneca mainly. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers.
Sector Healthcare
Industry -
Market cap 28bn
Data provided by /
/ Others were interested in
See all stocksFrequently asked questions
You need to open and fund a Saxo account to buy BeOne Medicines Ltd - ADR stock. Once the account is approved, you can login to the platform (SaxoInvestor or SaxoTrader), search for BeOne Medicines Ltd - ADR (by name) or ‘ONC:xnas’ (by ticker), choose the number of shares you wish to buy, and place your order.
The ticker symbol for BeOne Medicines Ltd - ADR is ONC:xnas. You can use this code to find the stock in our platforms and track its price and performance.
BeOne Medicines Ltd - ADR has its primary listing on NASDAQ. You can trade BeOne Medicines Ltd - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, BeOne Medicines Ltd - ADR is available to trade on SaxoInvestor and SaxoTrader. You can buy BeOne Medicines Ltd - ADR stock directly and include it as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like BeOne Medicines Ltd - ADR or others.